Figure 2
Kaplan-Meier actuarial analysis of all 351 patients for: (a) Biochemical control, overall survival and metastasis-free survival and (b) Biochemical control by risk group.
Figure 2 | Radiation Oncology
Kaplan-Meier actuarial analysis of all 351 patients for: (a) Biochemical control, overall survival and metastasis-free survival and (b) Biochemical control by risk group.